News
eXoZymes
EXOZ · NASDAQ
$4.12+$0.12 (+3.00%)TodayMarket closed ·
Prev close $4.00
Latest news
- Press releaseACCESS Newswire
eXoZymes Selects Curia as Commercial-Scale Manufacturing Partner for NCT
- News
12 Health Care Stocks Moving In Thursday's After-Market Session
- Press releaseACCESS Newswire
eXoZymes Inc. Announces Pricing of Public Offering of Common Stock and Warrants
- News
Earnings Scheduled For March 31, 2026
- Press releaseACCESS Newswire
With Refreshed Brand eXoZymes Sharpens Pharmaceutical Focus to Drive Platform Leverage and Long-Term Value Creation
- Press releaseACCESS Newswire
eXoZymes Provides Third Quarter 2025 Update at 5PM EST Today
- News
Earnings Scheduled For November 13, 2025
- Press releaseACCESS Newswire
eXoZymes Provides Second Quarter 2025 Update at 5PM EST Today
- News
12 Health Care Stocks Moving In Friday's Intraday Session
- Press releaseACCESS Newswire
eXoZymes Provides First Quarter 2025 and NCTx Subsidiary Update at 5PM EST Today
- News
Earnings Scheduled For April 2, 2025
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.